What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: AmBisome
97%DGNews: NeXstar Pharmaceuticals' AmBisome Receives First Line Approval
96%DGNews: FDA Approves Ambisome (Amphotericin) For Cryptococcal Meningitis In AIDS Patients
96%DGNews: Canada Approves Antifungal Agent AmBisome (Amphotericin B)
96%DGNews: Abelcet More Effective Than AmBisome In Leukemia Patients With Fungal Infections
95%DGNews: AmBisome Shows Proven Benefits Over Traditional Antifungal Therapy
95%DGNews: ICAAC: Ambisome As Effective And Safe As Amphotericin B For Meningitis
95%DGNews: AmBisome and DaunoXome Approved in Switzerland
94%DGNews: Indications Expanded for Antifungal AmBisome In Spain
94%DGNews: AmBisome Now Approved In UK For Presumed Fungal Infections
92%DGNews: AmBisome Approved In New Zealand, DaunoXome Approved In Australia
85%DGNews: Increased Liver Abnormalities With Voriconazole Prophylaxis Against Aspergillus in Lung Transplant Patients: Presented at ATS
83%DGNews: FDA Approves Antifungal Mycamine (Micafungin Sodium)
82%DGNews: Aptamer Stops Angiogenesis, Tumor Growth
77%DGNews: Micafungin as Effective as Liposomal Amphotericin B in Children With Invasive Candidiasis or Candidaemia: Presented at ECCMID-ICC
73%DGNews: DaunoXome Approved by FDA As First-line Therapy For Kaposi's Sarcoma
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.